Reglan

Reglan, also known as metoclopramide, is prescribed to treat gastrointestinal disorders (GERD), nausea, acid reflux and nausea associated with migraine headaches. Reglan may also have been prescribed for women who are pregnant and experiencing morning sickness as well as mothers who are breastfeeding infants and children. Reglan has also been given to premature infants during the feeding process to assist in digestion of formula. The drug was also used to treat nausea associated with the treatment of cancer patients.

Metoclopramide is available in several forms including:
• Reglan Tablets
• Reglan Oral Disintegrating Tablets
• Metoclopramide Oral Solution
• Reglan Injection

It is estimated that two-million people in the United States took metoclorpamide containing drugs like Reglan. Reglan and other metoclopramide containing drugs are the leading cause of drug-induced movement disorders like Tardive Dyskinesia. On January 26, 2009 an alert warning was issued by the FDA about chronic use of metoclopramide containing drugs, including Reglan. A warning is now required on the box of metoclopramide containing drugs.

Reglan has been linked to the extremely serious movement disorder Tardive Dyskinesia. Tardive dyskinsia’s rarely reversible symptoms include random movement of the tongue, lips or jaw as well as facial grimacing, movement of arms, legs, fingers and toes along with swaying movements of the trunk or hips. Individuals who have developed Tardive Dykinesia after taking Reglan or another metoclopromide containing drug should not only seek medical assistance, but legal assistance as well.

If you or a loved one took Reglan and developed a movement disorder like Tardive Dyskinesia, please contact the Johnson Law Group today.